Why Are Investors Looking At The Biotech Sector?
Because… its BIG!
Big Pharma & Medical Device Market Headlines:
“Global Biotechnology Market is set to exceed USD 775 billion by 2024”
“Medical Devices… a disruptive market of $410 billion until 2023…” (Forbes) https://www.forbes.com/sites/yiannismouratidis/2018/12/09/the-rise-of-use-of-medical-devices-force-fda-to-change-the-rules/#383d00b32101
The Biotechnology in the US industry consists of Human health technologies (including drugs/medicines & medical devices), animal health, marine and terrestrial microbial technologies, environmental remediation and natural resource recovery, agriculture and aquaculture technologies and industrial technologies.
Over the past five years, the Biotechnology in the US industry has grown by 1.5% to reach revenue of $108bn in 2018. In the same timeframe, the number of businesses has grown by 1.1% and the number of employees has grown by 0.2%.
Biotechnology Market size is set to exceed USD 775 billion by 2024; according to a new research report by Global Market Insights. Growing incidence of chronic diseases will boost biotechnology market growth over the forecast timeline.
Innovations in biotechnology sector is expected to upsurge revenue size during the forecast period. Innovations… with rising demand for novel biotechnological products will favor business growth. Wide-ranging applications coupled with growing demand for effective drugs and vaccines should favor business growth. Improving healthcare access in areas of unmet medical needs and growing R&D expenses for biotechnology advances will spur revenue size. Moreover, rising demand for agriculture based products and growing demand for biotechnology practices in clinical research will endure to foster biotechnology industry growth. https://www.gminsights.com/industry-analysis/biotechnology-market
U.S. remains the largest medical device market in the world, with a market size of around $156 billion as well as representing about 40 percent of the global medical device market last year alone
Compared to several other industries including automotive, defense, and telecommunications, the medical device industry invests a higher percentage of yearly revenues into product innovation, reflecting the competitive nature of the industry and constant innovation and improvement of existing technologies.
The medical device industry relies on several industries where the United States holds a competitive advantage, including microelectronics, telecommunications, instrumentation, biotechnology, and software development. Collaborations have led to recent advances including neuro-stimulators, stent technologies, biomarkers, robotic assistance, and implantable electronic devices. Since innovation fuels the medical device sector’s ongoing quest for better ways to treat and diagnose medical conditions, when coupled with patient life expectancy increasing and aging populations globally, the medical device sector should continue growing at a positive rate in the future.
Forbes said the following: “It’s been well appreciated by market analysts that the universe of U.S. public equities has shrunk remarkably over the past 20 years, from nearly 8000 listed companies in 1996 to just over 4000 today. A combination of fewer gains (new listings like IPOs) and more listing losses (from M&A and delistings) has dramatically reduced the pool of public stocks investors can trade by almost 50% over two decades.
Today we are five years into a sustained, open, and accommodative IPO market, the most prolific for new offerings in biotech history. Since 2011, we’ve seen over a 50% increase in the number of publicly-traded biotech companies… demand for biotech IPOs and the opportunity to back new potential therapies has grown considerably vs in the past two decades. Biotech, and healthcare at large, have represented nearly two of every five IPOs, according to Renaissance Capital, over the past few years – 3-4x greater than biotech’s share of the private company universe.
FinancialNewsMedia.com has many years of experience assisting public companies, large and small, navigate a wide range of Financial Public Relations needs for Micro Cap to Small Cap to Large Cap Companies. Our approach includes strategic orientated goals for our clients that can save time and money while delivering the right outcomes. Our News Media campaigns are strategically executed to generate maximum exposure and stimulate retail investor awareness.
FinancialNewsMedia.com provides top tier media solutions to disseminate, amplify and target a company’s news and corporate developments utilizing innovative news media services, social media and multimedia platforms. We effectively distribute vitally important news & content with measured results across traditional, digital and social channels. Combining the most cost effective multimedia-channels and content distribution communications technology with powerful workflow tools and cutting edge online media platforms, FinancialNewsMedia.com enables public companies and IR professionals to engage opportunity everywhere it exists.
FinancialNewsMedia.com provides established and emerging public companies a suite of comprehensive products & solutions along with one of the kind strategic consulting services built on years of Financial Marketing, Information Technology and Communications experience. FNM understands the importance to successfully establishing corporate visibility throughout the high paced investment community and financial marketplace and we are committed to providing the markets highest quality, one source destination for publicly traded corporations and IR professionals. For more information, visit the FNM Product & Services or email us at solutions@FinancialNewsMedia.com.
FinancialNewsMedia.com (FNM) is a leading provider of proactive news distribution services and engaging financial public relations. FNM specializes in Powerful Dissemination Solutions, Targeted Media Communications, Financial Outreach & Awareness Campaigns, Amplified News Services and so much more. We are continually leveraging the latest communications technology and influential media platforms providing a comprehensive suite of powerful tools for today’s emerging public companies to successfully reach the retail investor community. Now more than ever, a company’s vitally important news and corporate message is effectively amplified to a larger audience utilizing unparalleled multimedia channels aimed at increasing exposure and maximizing corporate online visibility in today’s highly competitive financial marketplace.